Search - tctmd.com

Displaying 1 - 10 of 10

Sort: Relevancy | Date

NSTEMI Patients With CKD See Better Outcomes With Invasive Strategy

News Conference News TCT 2021

NSTEMI Patients With CKD See Better Outcomes With Invasive Strategy

October 22, 2021

Fivefold Increase in Impella Use for Cardiogenic Shock in Acute MI: US Data

News Daily News

Fivefold Increase in Impella Use for Cardiogenic Shock in Acute MI: US Data

July 06, 2021

Unplanned PCI Rare After TAVI, but Operators Get Good Results

News Daily News

Unplanned PCI Rare After TAVI, but Operators Get Good Results

Michael O'Riordan

January 18, 2021

News Daily News

Stress Cardiomyopathy Up in Ohio—but Not Directly Due to COVID-19

Yael L. Maxwell

July 13, 2020

COVID-19, ACE Inhibitors, and ARBs: Multiple Studies Show No Increased Risk

News Daily News

COVID-19, ACE Inhibitors, and ARBs: Multiple Studies Show No Increased Risk

Michael O'Riordan

May 05, 2020

More Adverse Events, Higher Costs With Impella: New Observational Studies

News Conference News AHA 2019

More Adverse Events, Higher Costs With Impella: New Observational Studies

November 17, 2019

NCSI Strategy for Acute MI Cardiogenic Shock Reaps Better Survival

News Conference News TCT 2019

NCSI Strategy for Acute MI Cardiogenic Shock Reaps Better Survival

October 10, 2019

In-Hospital Mortality Hasn’t Budged Despite Changes in MCS for Cardiogenic Shock

News Conference News TCT 2019

In-Hospital Mortality Hasn’t Budged Despite Changes in MCS for Cardiogenic Shock

October 04, 2019

Leave It Be: PCI for Stable CAD Before or With TAVR Does Not Lower Mortality Risk

News Conference News TCT 2019

Leave It Be: PCI for Stable CAD Before or With TAVR Does Not Lower Mortality Risk

Michael O'Riordan

September 29, 2019

Unplanned Readmissions Within 30 Days Post-PCI Affect Nearly One in 10 US Patients

News Daily News

Unplanned Readmissions Within 30 Days Post-PCI Affect Nearly One in 10 US Patients

April 04, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.